M
M H Bagheri
Researcher at Tehran University of Medical Sciences
Publications - 9
Citations - 526
M H Bagheri is an academic researcher from Tehran University of Medical Sciences. The author has contributed to research in topics: Liver transplantation & Liver disease. The author has an hindex of 5, co-authored 9 publications receiving 496 citations.
Papers
More filters
Journal Article
Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis
Mehdi Mohamadnejad,Kamran Alimoghaddam,Mandana Mohyeddin-Bonab,M H Bagheri,Maryam Bashtar,Hossein Ghanaati,Hossein Baharvand,Ardeshir Ghavamzadeh,Reza Malekzadeh +8 more
TL;DR: Mesenchymal stem cell transplantation seems to be feasible and safe in the treatment of decompensated liver cirrhosis and the quality of life of all four patients improved by the end of follow-up.
Journal ArticleDOI
Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis.
Mehdi Mohamadnejad,Mehrnaz Namiri,M H Bagheri,Seyed Mahmoud Hashemi,Hossein Ghanaati,Narges Zare Mehrjardi,Saeed Kazemi Ashtiani,Reza Malekzadeh,Hossein Baharvand +8 more
TL;DR: In this article, the authors evaluated safety and feasibility of autologous bone marrow-enriched CD34+ hematopoietic stem cells through the hepatic artery in patients with decompensated cirrhosis.
Journal ArticleDOI
Intraportal Infusion of Bone Marrow Mononuclear or CD133+ Cells in Patients With Decompensated Cirrhosis: A Double-Blind Randomized Controlled Trial
Mehdi Mohamadnejad,Massoud Vosough,Shirin Moossavi,Sepideh Nikfam,Soura Mardpour,Shahram Akhlaghpoor,Mandana Ashrafi,Vajiheh Azimian,Neda Jarughi,Seyedeh-Esmat Hosseini,Fatemeh Moeininia,M H Bagheri,Maryam Sharafkhah,Nasser Aghdami,Reza Malekzadeh,Hossein Baharvand +15 more
TL;DR: The data justify further study of CD133+ therapy in cirrhotic patients and a trend was seen toward a higher mean absolute change in the MELD score in patients who had received CD133+, compared with placebo at month 3 after infusion.
Journal ArticleDOI
Results of Liver Transplantation: Analysis of 140 Cases at a Single Center
Seyed Ali Malek-Hosseini,Alireza Mehdizadeh,H Salahi,Mehdi Saberi-Firouzi,Kamran Bagheri-Lankarani,Ali Bahador,Mohammad Hadi Imanieh,Saman Nikeghbalian,M. Lahsaee,Mohammad Bagher Khosravi,M.M Arasteh,M H Bagheri,Bita Geramizadeh,Ali Razmkon,Seyed Ziaeddin Tabei +14 more
TL;DR: The experience that the Shiraz Organ Transplant Center has had with liver transplantation indicated success comparable to that noted in other reports, and the calculated trend suggests that a goal of 100 transplantations for 2005 is within reach.
Journal Article
Cell-Based Regenerative Therapy as an Alternative to Liver Transplantation for End-Stage Liver Disease: Experience from Iran
Reza Malekzadeh,Mehdi Mohamadnejad,Kamran Alimoghaddam,M H Bagheri,Hossein Baharvand,A. Ghavamzadeh +5 more
TL;DR: The experience with cell therapy in treatment of chronic liver disease in Iran is presented and there is serious concern about the long-term safety of stem cell therapy and the possibility of tumor development.